• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种八价肺炎球菌结合疫苗、PncD和PncT的婴幼儿的血清和唾液抗荚膜抗体

Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.

作者信息

Nurkka A, Ahman H, Yaich M, Eskola J, Käyhty H

机构信息

National Public Health Institute, Mannerheimintie 166, FIN-00300, Helsinki, Finland.

出版信息

Vaccine. 2001 Oct 12;20(1-2):194-201. doi: 10.1016/s0264-410x(01)00250-x.

DOI:10.1016/s0264-410x(01)00250-x
PMID:11567764
Abstract

We studied the immunogenicity of two octavalent pneumococcal (Pnc) conjugate vaccines; Pnc polysaccharides (PS) of serotypes 3, 4, 6B, 9V, 14, 18C, 19F, and 23F were conjugated to diphtheria or tetanus toxoid (PncD and PncT, respectively). Fifty healthy Finnish infants were vaccinated at the ages of 2, 4, 6, and 15 months with either PncD or PncT. Serum IgG antibodies to the vaccine serotypes were analysed by enzyme-linked immunosorbent assay (EIA). All eight PSs induced a significant antibody response both after the primary series and after the booster. Response to PncD was higher for PSs 3, 9V, 14 and 18C and to PncT for serotype 4. Salivary IgA and IgG anti-Pnc antibodies were measured for serotypes 4, 6B, 9V, 14, 18C, and 19F. Mucosal antibodies were found rarely after the primary series but in a greater proportion after the booster. In conclusion, both vaccines were immunogenic.

摘要

我们研究了两种八价肺炎球菌(Pnc)结合疫苗的免疫原性;3、4、6B、9V、14、18C、19F和23F血清型的Pnc多糖(PS)分别与白喉类毒素或破伤风类毒素结合(分别为PncD和PncT)。五十名健康的芬兰婴儿在2、4、6和15月龄时接种了PncD或PncT。通过酶联免疫吸附测定(EIA)分析针对疫苗血清型的血清IgG抗体。所有八种PS在初次免疫系列后和加强免疫后均诱导了显著的抗体反应。对于3、9V、14和18C血清型,对PncD的反应更高,对于4血清型,对PncT的反应更高。检测了4、6B、9V、14、18C和,19F血清型的唾液IgA和IgG抗Pnc抗体。初次免疫系列后很少发现黏膜抗体,但加强免疫后比例更高。总之,两种疫苗均具有免疫原性。

相似文献

1
Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.接种八价肺炎球菌结合疫苗、PncD和PncT的婴幼儿的血清和唾液抗荚膜抗体
Vaccine. 2001 Oct 12;20(1-2):194-201. doi: 10.1016/s0264-410x(01)00250-x.
2
Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.接种七价肺炎球菌结合疫苗的婴幼儿的血清和唾液抗荚膜抗体
Pediatr Infect Dis J. 2001 Jan;20(1):25-33. doi: 10.1097/00006454-200101000-00006.
3
Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.幼儿肺炎球菌结合疫苗接种:以循环抗体分泌细胞和唾液抗体衡量的黏膜抗体反应
Pediatr Infect Dis J. 1999 Sep;18(9):764-72. doi: 10.1097/00006454-199909000-00005.
4
Safety and immunogenicity of two octavalent pneumococcal conjugate vaccines in American Indian infants.
Vaccine. 2004 Mar 12;22(9-10):1260-4. doi: 10.1016/j.vaccine.2003.09.026.
5
Immune response to octavalent diphtheria- and tetanus-conjugated pneumococcal vaccines is serotype- and carrier-specific: the choice for a mixed carrier vaccine.对八价白喉和破伤风结合肺炎球菌疫苗的免疫反应具有血清型和载体特异性:混合载体疫苗的选择
Pediatr Infect Dis J. 2002 Jun;21(6):548-54. doi: 10.1097/00006454-200206000-00013.
6
Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.用与白喉或破伤风类毒素结合的肺炎链球菌荚膜多糖免疫的婴幼儿唾液中的抗荚膜抗体。
Vaccine. 2000 Jan 18;18(13):1218-26. doi: 10.1016/s0264-410x(99)00393-x.
7
Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants.婴儿对7价肺炎球菌结合疫苗的初次和加强唾液抗体反应。
J Infect Dis. 2000 Oct;182(4):1260-3. doi: 10.1086/315834. Epub 2000 Aug 31.
8
IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.成人接种肺炎球菌结合疫苗后抗体的IgG亚类分布
Vaccine. 1999 Apr 9;17(15-16):1889-97. doi: 10.1016/s0264-410x(98)00475-7.
9
Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.一种十一价混合载体肺炎链球菌荚膜多糖-白喉类毒素或破伤风蛋白结合疫苗在芬兰和以色列婴儿中的耐受性和免疫原性。
Pediatr Infect Dis J. 2004 Feb;23(2):91-8. doi: 10.1097/01.inf.0000109221.50972.53.
10
Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.在幼儿中,与破伤风类毒素或白喉类毒素结合的含6B、14、19F和23F多糖的四价肺炎球菌疫苗的安全性和免疫原性,以及其被天然多糖抗原加强免疫的能力。
Pediatr Infect Dis J. 1997 Nov;16(11):1053-9. doi: 10.1097/00006454-199711000-00010.

引用本文的文献

1
Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.系统评价肺炎球菌结合疫苗接种方案对免疫原性的影响。
Pediatr Infect Dis J. 2014 Jan;33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S119-29. doi: 10.1097/INF.0000000000000079.
2
Protein carriers of conjugate vaccines: characteristics, development, and clinical trials.结合疫苗的蛋白载体:特性、研发和临床试验。
Hum Vaccin Immunother. 2013 Dec;9(12):2505-23. doi: 10.4161/hv.26109. Epub 2013 Aug 16.
3
Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy.
婴儿期接种肺炎球菌结合疫苗后,肺炎球菌抗体的浓度和高亲和力至少持续4年。
Clin Vaccine Immunol. 2013 Jul;20(7):1034-40. doi: 10.1128/CVI.00039-13. Epub 2013 May 8.
4
Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.两种七价肺炎球菌结合疫苗在芬兰中耳炎疫苗试验中引发的功能性抗体。
Infect Immun. 2007 Apr;75(4):1794-800. doi: 10.1128/IAI.01673-06. Epub 2007 Jan 29.
5
Subclass distribution of natural salivary IgA antibodies against pneumococcal capsular polysaccharide of type 14 and pneumococcal surface adhesin A (PsaA) in children.儿童中针对14型肺炎球菌荚膜多糖和肺炎球菌表面黏附素A(PsaA)的天然唾液IgA抗体的亚类分布。
Clin Exp Immunol. 2006 Mar;143(3):543-9. doi: 10.1111/j.1365-2249.2006.03009.x.
6
Salivary antibodies induced by the seven-valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial.七价肺炎球菌结合疫苗(PncOMPC)在芬兰中耳炎疫苗试验中诱导产生的唾液抗体。
BMC Infect Dis. 2005 May 27;5:41. doi: 10.1186/1471-2334-5-41.
7
Advances in pneumococcal vaccines: advantages for infants and children.肺炎球菌疫苗的进展:对婴幼儿的益处
Drugs. 2005;65(2):229-55. doi: 10.2165/00003495-200565020-00005.
8
Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial.在芬兰中耳炎疫苗试验中,七价肺炎球菌结合疫苗PncCRM和PncOMPC诱发抗体的动力学和亲和力。
Infect Immun. 2005 Jan;73(1):369-77. doi: 10.1128/IAI.73.1.369-377.2005.
9
Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.针对致病性鼻咽部细菌的疫苗的黏膜免疫学
J Clin Pathol. 2004 Oct;57(10):1015-21. doi: 10.1136/jcp.2004.016253.
10
Effects of sample collection and storage methods on antipneumococcal immunoglobulin A in saliva.样本采集和储存方法对唾液中抗肺炎球菌免疫球蛋白A的影响。
Clin Diagn Lab Immunol. 2003 May;10(3):357-61. doi: 10.1128/cdli.10.3.357-361.2003.